Rose Report Podcast – July 2017
This article was originally published in The Rose Sheet
The Rose Sheet's editorial team counts off top news items in the cosmetics and dietary supplement sectors in July. In this installment we discuss developments under the EU’s cosmetics animal-testing ban, cosmetic preservatives positioned for elimination, and a bill advancing in California that would tighten requirements for continuity marketing; On the supplement side, warning letters are issuing regularly, but investments in the industry also are up, while innovative medical foods and probiotics are creating new growth opportunities.
You may also be interested in...
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.